Literature DB >> 10803603

Activin A release into the circulation is an early event in systemic inflammation and precedes the release of follistatin.

K L Jones1, J N Brauman, N P Groome, D M de Kretser, D J Phillips.   

Abstract

Recent evidence suggests a role for activin A, and its binding protein, follistatin, in inflammatory pathways. However, whether activin is released systemically during inflammation is not known. In this study, a release of activin A into the circulation occurred in sheep within 1 hour of injection of lipopolysaccharide. This rapid peak in activin A preceded the release of the key inflammatory cytokines, tumor necrosis factor-alpha and interleukin-6. Follistatin release into the circulation occurred some 4 hours after the peak of activin A and continued out to 24 hours from lipopolysaccharide treatment. These data are the first to document a circulatory response of activin A to an inflammatory stimulus, and together with previous findings, suggest that activin A may have both pro- and anti-inflammatory actions in regulating cytokine-driven pathways.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10803603     DOI: 10.1210/endo.141.5.7531

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  20 in total

1.  A novel role for follistatin in hypersensitivity following cystitis.

Authors:  Amber D Shaffer; Bin Feng; Jun-Ho La; Sonali C Joyce; G F Gebhart
Journal:  Neurourol Urodyn       Date:  2015-12-29       Impact factor: 2.696

2.  Activin A is a critical component of the inflammatory response, and its binding protein, follistatin, reduces mortality in endotoxemia.

Authors:  Kristian L Jones; Ashley Mansell; Shane Patella; Bernadette J Scott; Mark P Hedger; David M de Kretser; David J Phillips
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-02       Impact factor: 11.205

3.  Activin A: a potential therapeutic target for characterizing and stopping joint pain early in rheumatoid arthritis patients.

Authors:  Fei Dong; Xijing He
Journal:  Inflammation       Date:  2014-02       Impact factor: 4.092

4.  Placental and maternal serum activin A in spontaneous and induced labor in late-term pregnancy.

Authors:  L Funghi; M Torricelli; R Novembri; S Vannuccini; G Cevenini; M Di Tommaso; F M Severi; F Petraglia
Journal:  J Endocrinol Invest       Date:  2017-06-13       Impact factor: 4.256

5.  Circulating follistatin in patients with chronic kidney disease: implications for muscle strength, bone mineral density, inflammation, and survival.

Authors:  Tetsu Miyamoto; Juan Jesús Carrero; Abdul Rashid Qureshi; Björn Anderstam; Olof Heimbürger; Peter Bárány; Bengt Lindholm; Peter Stenvinkel
Journal:  Clin J Am Soc Nephrol       Date:  2011-02-24       Impact factor: 8.237

6.  Activin A suppresses interleukin-1-induced matrix metalloproteinase 3 secretion in human chondrosarcoma cells.

Authors:  Deh-Ming Chang; Shao-Hsiang Liu; Herng-Sheng Lee; Jenn-Hung Lai; Chen-Hung Chen
Journal:  Rheumatol Int       Date:  2007-04-14       Impact factor: 2.631

7.  Beneficial effects of follistatin in hepatic ischemia-reperfusion injuries in rats.

Authors:  Mami Kanamoto; Mitsuo Shimada; Yuji Morine; Tomoharu Yoshizumi; Satoru Imura; Toru Ikegami; Hiroki Mori; Yusuke Arakawa
Journal:  Dig Dis Sci       Date:  2010-09-08       Impact factor: 3.199

8.  Activin A is stimulated by tumor necrosis factor-alpha and modulates collagen gene expression in human amniotic cells.

Authors:  Y Abe; M Komatsubara; M Saito; M Toda; H Shinozaki; T Tamura; Y Kasahara; H Sedakata; T Minegishi
Journal:  J Endocrinol Invest       Date:  2013-02-04       Impact factor: 4.256

9.  Delayed activin A administration attenuates tissue death after transient focal cerebral ischemia and is associated with decreased stress-responsive kinase activation.

Authors:  Shibani S Mukerji; Riley N Rainey; Jamie L Rhodes; Alison K Hall
Journal:  J Neurochem       Date:  2009-09-24       Impact factor: 5.372

10.  Role of activins and inducible nitric oxide in the pathogenesis of ectopic pregnancy in patients with or without Chlamydia trachomatis infection.

Authors:  Bassem Refaat; Majedah Al-Azemi; Ian Geary; Adrian Eley; William Ledger
Journal:  Clin Vaccine Immunol       Date:  2009-08-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.